Armon Sharei, PhD (@ArmonSharei) header
Armon Sharei, PhD (@ArmonSharei) profile picture

Cell Engineer. Founder/CEO of Portal Bio, prev. founder/CEO of SQZ Biotech (IPO). Host of Boba & Biotech 🧋

San Francisco Bay Area
Joined February 2013
Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)Photo by Armon Sharei, PhD (@ArmonSharei)
1/ Unpopular take: in vivo CAR-T will get sandwiched between ex vivo CARs and biologics (TCEs, ADCs). I think its only durable advantage is cost, and that's solvable. 🧵
1
1
184
Armon Sharei, PhD retweeted
We’ve been quiet here, but our cells haven’t! We’re back on X with a hypothesis: Galaxy-i deserves a 2027 Scientists’ Choice Award. 🏆 Help us prove it: selectscience.jotform.com/26…
1
1
1
68
1/ Looks like Claude kicks butt at siRNA design! (even though I tend to cheer for Gemini)
1
1
69
5/ The experiment: we used Portal’s research-scale system (the Gateway) to deliver all the sequences to primary human PBMCs (T, B, NK cells and monocytes) and did the readout on D3.
1
1
13
Armon Sharei, PhD retweeted
Incredible data from Armon Sharei at @portal_biotech this week. @AnthropicAI's Claude designed siRNA that knocked down two different genes. @OpenAI's GPT-5 and @GoogleDeepMind's Gemini designed sequences that did nothing. Armon used the same one line prompt across all three models: "Please give me your top 3 siRNA sequences for knocking down [gene] in human peripheral blood mononuclear cells." siRNA is small interfering RNA. A short piece of RNA that finds the matching mRNA inside a cell and destroys it. The gene stays intact, the message never becomes a protein. The hard part is picking a sequence that hits the right transcript and nothing else. The two targets were B2M and CD45. Both well known, both already carrying real clinical programs. B2M, beta-2 microglobulin. The shared subunit of every MHC class I molecule. - @CRISPRTX zugocaptagene geleucel, formerly CTX112. CD19 allogeneic CAR T, B2M knocked out for immune evasion - @SanaBiotech SC291. CD19 allogeneic CAR T on their hypoimmune platform: B2M and CIITA out, CD47 in CD45, also called PTPRC. The pan-leukocyte phosphatase, on every white blood cell and almost nothing else. - @ActiniumPharma Iomab-B, an iodine-131 anti-CD45 antibody, Phase 3 in AML One is a target for making allogeneic T cells. The other is a target for clearing a patient's own blood cells out of the marrow so that a donor stem cell graft has room to engraft. The results, with all sequences delivered straight into the cytosol of primary human PBMCs on Portal's Gateway and read out at day 3: B2M, non-targeting control 7.5% - Claude: 74.7% - GPT-5: 26.8% - Gemini: 5.5% CD45, non-targeting control 0.7% - Claude: 97.9% - GPT-5: 2.8% - Gemini: 5.6% The type of design thinking necessary to come up with an siRNA construct used to take specialized skills and know-how. Today, in one prompt, we have access to 0-shot siRNA design.
6
1
14
1,210
💸 What do investment bankers actually do? 🎙️Listen to Episode 9 of Boba & Biotech with Armon Sharei featuring guest Mark Dempster on all streaming platforms today! 🎤Available on all streaming platforms! open.spotify.com/episode/5wX… — #biotech #IB #investmentbanking #startups
1
4
67
☠️It was part of his job to kill programs? 🎙️Listen to Episode 8 of Boba & Biotech with Armon Sharei featuring guest William Pao on all streaming platforms today! 🎤Available on all streaming platforms! open.spotify.com/episode/1kU… — #science #biotech #boba #startups
1
3
45
🧗AI’s biggest cliff… 🎙️Listen to Episode 8 of Boba & Biotech with Armon Sharei featuring guest William Pao on all streaming platforms today! open.spotify.com/episode/1kU… — #science #biotech #spotifypodcasts #boba #startups
1
3
62
📈Why most biotech startups fail… 🎙️Listen to Episode 6 of Boba & Biotech with Armon Sharei featuring guest Adam Jenkins on all streaming platforms today! open.spotify.com/episode/32u… — #science #biotech #spotifypodcasts #boba #startups
1
3
38
🚀The risks startups take to launch 🎙️Listen to Episode 5 of Boba & Biotech with Armon Sharei featuring guest Klavs Jensen on all streaming platforms today! open.spotify.com/episode/167… #science #biotech #spotifypodcasts #boba #startups
1
3
30